Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Related financial report
IMUX similar filings
- 19 Jan 23 Departure of Directors or Certain Officers
- 30 Dec 22 Entry into a Material Definitive Agreement
- 17 Nov 22 Other Events
- 3 Nov 22 Immunic, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
- 20 Oct 22 Immunic Reports Pre-Planned Phase 1b Interim Analysis of IMU-935 in Psoriasis Patients Confounded by High Placebo Rate
- 11 Oct 22 Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing
- 20 Sep 22 Immunic Announces Positive Results from Single and Multiple Ascending Dose Parts of Its Phase 1 Clinical Trial of IMU-856 in Healthy Human Subjects
Filing view
External links